These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 18820657)
41. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372 [TBL] [Abstract][Full Text] [Related]
42. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Bakri SJ; Kaiser PK Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990 [TBL] [Abstract][Full Text] [Related]
43. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632 [TBL] [Abstract][Full Text] [Related]
44. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases. Jonas JB; Schlichtenbrede F Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257 [TBL] [Abstract][Full Text] [Related]
45. The effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameter. Aras C; Ozdamar A; Aktunç R; Erçikan C Ophthalmic Surg Lasers; 1998 Aug; 29(8):621-7. PubMed ID: 9715485 [TBL] [Abstract][Full Text] [Related]
46. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680 [TBL] [Abstract][Full Text] [Related]
49. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Hayashi K; Hayashi H Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425 [TBL] [Abstract][Full Text] [Related]
50. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
51. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema]. Jonas JB; Degenring R Klin Monbl Augenheilkd; 2002 Jun; 219(6):429-32. PubMed ID: 12136438 [TBL] [Abstract][Full Text] [Related]
52. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study. Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140 [TBL] [Abstract][Full Text] [Related]
54. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501 [TBL] [Abstract][Full Text] [Related]
57. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Jonas JB; Spandau UH; Kamppeter BA; Harder B Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809 [TBL] [Abstract][Full Text] [Related]
58. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Ferrante P; Ramsey A; Bunce C; Lightman S Clin Exp Ophthalmol; 2004 Dec; 32(6):563-8. PubMed ID: 15575824 [TBL] [Abstract][Full Text] [Related]
59. Subconjunctival injection of triamcinolone acetonide in the management of corneal graft rejection and new vessels. Athanasiadis I; de Wit D; Tsatsos M; Patel AK; Sharma A J Clin Pharmacol; 2012 Apr; 52(4):607-12. PubMed ID: 21505087 [No Abstract] [Full Text] [Related]